Abstract
Chrysophanol, a naturally occurring anthraquinone compound found in various plants, fungi, and lichens, has garnered increasing attention for its potential therapeutic benefits, particularly in the context of inflammation-related disorders. This review aims to provide a comprehensive overview of the anti-inflammatory properties of chrysophanol and its potential as a therapeutic agent for intervention in inflammatory conditions. In this review, the current understanding of the molecular mechanisms underlying the anti-inflammatory effects of Chrysophanol, including its modulation of key inflammatory signaling pathways, such as NF- κB, MAPK, JAK-STAT, Nrf2, and other NLRP3 inflammasomes. Additionally, we discuss the evidence from in vitro and in vivo studies supporting the anti-inflammatory efficacy of chrysophanol in various experimental models of inflammation, including various inflammatory diseases. Furthermore, we explore the pharmacokinetic profile of Chrysophanol and other nanoformulations to understand its therapeutic potential. Overall, accumulating evidence suggests that chrysophanol holds promise as a novel therapeutic candidate for the management of inflammatory disorders, warranting further investigation and clinical translation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Recent Advances in Inflammation & Allergy Drug Discovery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
